0.4955
4.53%
-0.0235
Exicure Inc Borsa (XCUR) Ultime notizie
Exicure, Inc. Reports Third Quarter 2023 Financial Results - Business Wire
Business Wire
NewAmsterdam Pharma (NASDAQ:NAMS) and Exicure (NASDAQ:XCUR) Financial Review - Defense World
Defense World
Earnings Preview: Exicure, Inc. (XCUR) Q3 Earnings Expected to Decline - Yahoo Singapore News
Yahoo Singapore News
Exicure, Inc. (XCUR) Reports Q2 Loss, Misses Revenue Estimates - Yahoo New Zealand News
Yahoo New Zealand News
Why FMC Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Benzinga
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Benzinga
Exicure, Inc. and Bluejay Therapeutics Inc. Enter into a Patent License Agreement to Develop Cavrotolimod for the ... - Business Wire
Business Wire
Why Richardson Electronics Shares Are Trading Lower By 13%; Here Are 20 Stocks Moving Premarket
Benzinga
Why WD-40 Shares Are Trading Higher By Over 17%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Aehr Test Systems Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket - Markets Insider
Markets Insider
Why Icosavax Shares Are Trading Higher By Around 45%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Comtech Telecommunications Shares Are Trading Lower By Over 16%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Benzinga
US Stocks Down; Nonfarm Payrolls Rise By 199,000 In November
Benzinga
Why Hello Group Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket
Benzinga
Why Is Exicure (XCUR) Stock Up 57% Today? - InvestorPlace
InvestorPlace
Exicure, Inc. Received Nasdaq Delinquency Notice on Late Filing of its Form 10-Q - Business Wire
Business Wire
Exicure Appoints Paul Kang As CEO - citybiz
citybiz
Exicure, Inc. Reports First Quarter 2023 Financial Results and Provides Corporate Update - Business Wire
Business Wire
Exicure, Inc. Announces Investment in Korean SNS Platform Cyworld - Business Wire
Business Wire
3 Nano-Cap Penny Stocks to Buy for Explosive Gains in 2023 - InvestorPlace
InvestorPlace
Exicure continues death spiral, putting transaction of some kind on the table - Fierce Biotech
Fierce Biotech
Exicure, Inc. Announces Closing of Private Placement Transaction with CBI USA, Inc. and Changes to the Board of ... - Business Wire
Business Wire
Following $685 million-plus licensing agreement, Ann Arbor-based Evoq replaces CEO - Crain's Detroit Business
Crain's Detroit Business
Exicure, Inc. Announces Termination of AbbVie and Ipsen Collaboration Agreements - Business Wire
Business Wire
Exicure Lays off Two-Thirds of Workforce, Suspends R&D in Restructuring - BioSpace
BioSpace
Exicure, Inc. Enters Into Definitive Agreement With CBI USA, Inc. for $5.4 Million Equity Financing and Announces ... - Business Wire
Business Wire
eExicure XCUR Stock Price is up, can it go higher? URGENT REPORT - Small Cap Exclusive
Small Cap Exclusive
XCUR Stock Price is liquid, can it go higher? URGENT REPORT - Small Cap Exclusive
Small Cap Exclusive
EXICURE DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been ... - Business Wire
Business Wire
Exicure hires new CEO after Brian Bock leaves after only two months - The Business Journals
The Business Journals
INVESTOR ACTION ALERT: The Schall Law Firm Encourages Investors in Exicure, Inc. with Losses of $100,000 to ... - AccessWire
AccessWire
Exicure Winds Down XCUR-FXN Program for Friedreich's Ataxia - Friedreich's Ataxia News
Friedreich's Ataxia News
Bill Gates Slashes Investment in This Penny Biotech Stock - Barron's
Barron's
Ipsen and Exicure to develop therapies for neurodegenerative disorders - Pharmaceutical Technology
Pharmaceutical Technology
Ipsen puts down $20M in $1B deal with Exicure for rare neuro disorders - Fierce Biotech
Fierce Biotech
Revisiting The Investment Thesis On Exicure (NASDAQ:XCUR) - Seeking Alpha
Seeking Alpha
Exicure Announces Issuance of Two New U.S. Patents and A New Patent Allowance Covering Cavrotolimod Through ... - Business Wire
Business Wire
Skender completes first biotech lab space and base-building work for Sterling Bay's life sciences project – REJournals - REjournals.com
REjournals.com
Allergan pays Exicure $25M to discover nucleic acid hair loss drugs - Fierce Biotech
Fierce Biotech
Exicure Announces License and Development Agreement with Dermelix Biotherapeutics in Rare Genetic Skin Diseases - Business Wire
Business Wire
Exicure CEO Giljohann develops breakthrough ‘spherical nucleic acid - Crain's Chicago Business
Crain's Chicago Business
Purdue Pharma and Exicure Announce Strategic Research Collaboration Agreement to Discover and Develop a ... - Business Wire
Business Wire
Capitalizzazione:
|
Volume (24 ore):